1. Market Research
  2. > Pathology Industry

Insulin Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Hormone, Biosimilar, Anti-Infective, Infusion Pump, Pharmaceutical, Vitamin, Insulin Pump, Cancer Diagnostic, Medical Devices, Needle, Biopharmaceutical, Glucose Monitor, Injectable Delivery, Protein, Syringe, Therapeutics, Medical, Monoclonal Antibody, Clinical Trial.


 
1-10 of about 200 reports for Insulin

Purchase Reports From Reputable Market Research Publishers

Insuline Medical Ltd

Insuline Medical Ltd

  • $ 99
  • Company report
  • January 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Insuline Medical Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

Human Insulin Market - Drugs , Type , Brands , Delivery Devices , Applications  - Forecasts to 2020

Human Insulin Market - Drugs , Type , Brands , Delivery Devices , Applications - Forecasts to 2020

  • $ 4 650
  • Industry report
  • January 2016
  • by MarketsandMarkets

The global human insulin market is poised to reach ~USD 39.13 billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. North America is expected to hold the largest share of the global human insulin ...

Insulin Lispro  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Insulin Lispro - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Insulin Glargine  - Comprehensive patent search

Insulin Glargine - Comprehensive patent search

  • $ 10 118
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

Insulin Aspart  - Comprehensive patent search

Insulin Aspart - Comprehensive patent search

  • $ 10 118
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

Insulin Lispro  - Comprehensive patent search

Insulin Lispro - Comprehensive patent search

  • $ 10 118
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Imagine having your own team of pharmaceutical patent experts at the click of a button. Used by the world’s leading pharmaceutical companies and legal teams for over 10 years, Ark In-depth Searches are ...

Insulin Aspart  - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

Insulin Aspart - Patent, Extension and Data Exclusivity Expiry Snapshot (fifty-one countries)

  • $ 1 523
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Insulin Aspart, Insulin Degludec  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Insulin Aspart, Insulin Degludec - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Insulin Lispro  - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

Insulin Lispro - Patent, Extension and Data Exclusivity Expiry Snapshot (nine countries)

  • $ 653
  • Company report
  • January 2016
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, ...

Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2016

Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “Insulin Like Growth Factor 1 (IGF-1) Activators-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around ...

About 5 300 reports for Insulin

Download Unlimited Documents from Trusted Public Sources

Fructose Markets in the US

  • January 2014
    26 pages
  • Sugar  

    Fructose  

    Insulin  

  • United States  

View report >

Pathology Description

January 2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.